The company is working on various vaccines, including against Covid-19, Lyme disease and chikungunya. Biotech stock jumped 216% in 2021.
Today’s news from Valneva as of 04/20/2022:
Valneva announced on April 14 that it had obtained a permission conditional grant from the British health agency MHRA in order to market VLA2001, its candidate vaccine against the coronavirus. This will concern adults between 18 and 50 years old wishing to receive their first vaccination.
It should be noted that this is the second authorization granted by a regulator for the Valneva vaccine, after the agreement of the authorities of the Kingdom of Bahrain last March. While the British government interrupted its agreement with the French laboratory in September 2021, Valneva is now negotiating with the Scottish authorities to supply up to 25,000 doses.
Suspendedand at the opening of the markets on April 14 in order to allow the distribution of the press release, the Valneva share price finally jumped 9.9% on the same day, closing at 16.76 euros. It fell by 1.01% during the session on Tuesday, April 19, while analysts listed on Boursorama see the stock exceed 20 euros within three months. Sales figures for the vaccine will be a determining factor in the evolution of the share price.
Valneva (VLA) price: what is the current price?
Here is Valneva’s live stock price.
Valneva share notice in the medium term: Valneva’s share price fell in early 2021, but should see new highs if significant progress is made on the Covid-19 front.
Valneva long-term share opinion: The 2021 performance of VLA stock should not be expected. With the effects of the Covid dissipating, profit taking may mitigate the rise in the stock.
Our overall opinion on Valneva (VLA) stock for 2022
Valneva Mirror Mag Rating: 8/10
68% of retail investor accounts lose money when trading CFDs with this provider. You need to ask yourself if you can afford to take the high risk of losing your money.
Opinion on what is driving down Valneva (VLA) stock
Valneva shares may be negatively impacted by a number of factors.
- Termination of contract with a partner
- Disappointments in vaccine expectations
Opinion on what makes Valneva stock rise (VLA)
Valneva shares can be positively impacted by a number of factors.
- Advances in vaccine development, including Covid
- New contracts with partners or institutions like the EU
- Upward growth revision
68% of retail investor accounts lose money when trading CFDs with this provider. You should ask yourself if you can afford to take the high risk of losing your money. eToro users in France cannot open positions to buy real crypto assets, all orders are opened as CFDs.